Healthcare -
Biotechnology - NASDAQ - US
$ 2.46
-0.806 %
$ 85 M
Market Cap
-2.62
P/E
GNLX - RESEARCH & DEVELOPMENT
Research & Development GNLX - Genelux Corporation
12.8 M
LAST VALUE
42.14%
2 YEAR CAGR
0.00%
5 YEAR CAGR
0.00%
10 YEAR CAGR